Porcine reproductive and respiratory syndrome (PRRS) is a highly contagious immunosuppressive disease caused by the porcine reproductive and respiratory syndrome virus (PRRSV) that is characterized by a highly variable gene sequence and a high rate of recombination, thereby contributing to difficulties in the clinical prevention and control of this virus. Glycosylated protein 3 (GP3) is the most glycosylated protein in PRRSV, and is closely associated with the composition of PRRSV virus particles, infection, and immune evasion. This review summarizes the structural features, genetic evolutionary patterns, glycosylation of GP3 and its interactions with other PRRSV and host proteins, associations with PRRSV infection and virulence, and immunomodulatory roles. Additionally, it provides an overview of research progress on monoclonal antibodies and vaccines targeting GP3. This study aims to provide a theoretical foundation for better understanding the structure and function of GP3, of the mechanisms of PRRSV infection, and the development of novel vaccines.

The Akabane virus (AKAV) is a significant member of the Orthobunyavirus genus, with its envelope glycoprotein Gc, focusing on its molecular structural features, immunoregulatory mechanisms, and application value in pathogen diagnosis and vaccine design. As a key structural protein of AKAV, Gc mediates virus adsorption and neutralizing antibody recognition through the N-terminal highly variable region (HVR), while the C-terminal conserved region (CR) dominates the membrane fusion process, and its glycosylation modification has a significant regulatory effect on protein function. In clinical diagnostics, serological assays based on Gc proteins (e.g., ELISA, immunochromatographic test strips) have been standardized; in vaccine development, the neutralizing epitope of Gc proteins has become a core target for subunit vaccine design. Follow-up studies were deeply needed to analyze the structure-function interaction mechanism of Gc proteins to provide theoretical support for the construction of a new type of AKAV prevention and control system.

Porcine reproductive and respiratory syndrome virus (PRRSV) poses a significant threat to the global swine industry. In this study, the genetic diversity, evolutionary dynamics, and key antigenic characteristics of the PRRSV-1 GP5 gene in China were systematically investigated. A total of 114 Chinese PRRSV-1 GP5 sequences, isolated between 1999 and 2024, were analyzed alongside global reference strains. The nucleotide and amino acid sequence similarities ranged from 60.03% to 100% and from 48.72% to 100%, respectively, with mutation and deletion hotspots concentrated in the N-terminal hypervariable region. Phylogenetic analysis further classified the Chinese strains into four major lineages: Amervac-like, BJEU06-1-like, HKEU16-like, and NMEU09-1-like. Notably, a preliminary phylogenetic observation indicated that several recent Chinese PRRSV-1 isolates clustered topologically close to PRRSV-2 strains. However, as this finding is based solely on a single-gene tree and has not been validated by formal tests for convergent evolution, homoplasy, or selection pressure, it should be interpreted with caution and warrants further investigation using whole-genome data. A Bayesian evolutionary analysis estimated the evolutionary rate at 1.94 × 10⁻³ substitutions per site per year and the time to the most recent common ancestor at approximately 1910. No statistically significant recombination events were identified within the GP5 gene. The transmembrane topology of GP5 was highly conserved, whereas B-cell linear epitopes were enriched in the N-terminal extracellular region. This study establishes a useful molecular foundation for understanding PRRSV-1 evolution in China and offers valuable insights for the development of broad-spectrum vaccines and effective control strategies.

Porcine reproductive and respiratory syndrome, a highly contagious disease, poses a severe threat to the global swine industry. Its causative agent, PRRSV, induces reproductive disorders (abortion, stillbirth) in pregnant sows and respiratory disease in piglets. The host immune system is disrupted by PRRSV, and no specific antiviral drugs are currently available. Thus, vaccination is regarded as the primary strategy for PRRS prevention and control. GP4, a key minor structural protein of PRRSV with an estimated molecular weight of 32 kDa, contains four conserved N-glycosylation sites at residues 37, 84, 120 and 130. Critical neutralizing epitopes are harbored in its extracellular domain (amino acids 40–79). PRRSV binding to the host CD163 receptor is mediated by GP4, which also regulates viral assembly and release, and induces protective immune responses. Hence, GP4 is identified as a central target for PRRS vaccine development. In this review, GP4’s structural characteristics, genetic evolution and interaction mechanisms are summarized. Its roles in viral life cycle, virulence, immune evasion and potential applications are discussed, providing a theoretical reference for PRRSV control.